Term
| Impairments or Limitation: weakness/paralysis |
|
Definition
|
|
Term
| Impairments or Limitation: tone changes-spasticity, flaccidity, rigidity |
|
Definition
|
|
Term
| Impairments or Limitation: sensory loss/perceptual deficits |
|
Definition
|
|
Term
| Impairments or Limitation: coordination deficits |
|
Definition
|
|
Term
| Impairments or Limitation: balance dysfunction |
|
Definition
|
|
Term
| Impairments or Limitation: akinesia, bradykinesia, motor planning deficits |
|
Definition
|
|
Term
| Impairments or Limitation: cognitive limitations |
|
Definition
|
|
Term
| Impairments or Limitation: aphasia |
|
Definition
|
|
Term
| Impairments or Limitation: bed mobility |
|
Definition
|
|
Term
| Impairments or Limitation: transfers |
|
Definition
|
|
Term
| Impairments or Limitation: walking |
|
Definition
|
|
Term
| Impairments or Limitation: hygiene, dressing |
|
Definition
|
|
Term
| Impairments or Limitation: eating |
|
Definition
|
|
Term
| Impairments or Limitation: stair climbing |
|
Definition
|
|
Term
| Impairments or Limitation: inability to leave the home |
|
Definition
|
|
Term
| chronic neuroimmunologic disease of the CNS, characterized by random inflammatory episodes with myelin damage and scarring |
|
Definition
|
|
Term
| MS is a hereditary disease. T/F? |
|
Definition
| False. Exposure to environmental trigger msut also occur |
|
|
Term
| Who is more likely to develop MS men or women |
|
Definition
|
|
Term
|
Definition
| relapsing-remitting, secondary progressive, primary progressive, progressive relapsing |
|
|
Term
| MS patterns: clearly defined acute attacks with full recovery or a residual deficit upon recovery. Periosd between attacks characterized by lack of disease progression |
|
Definition
|
|
Term
| MS Patterns: with relapsing remitting MS what happens as more relapses occur |
|
Definition
|
|
Term
| MS Patterns: 70-75% of people are intially diagnosed with this pattern |
|
Definition
|
|
Term
| MS Patterns: begins with initial relapsing remitting course followed by progression at variable rate that may include occasional relapses and plateus |
|
Definition
|
|
Term
| MS Patterns: of the 70-75 who begin RRMS more than 50% will develop this pattern within 10 years, and 90% within 25 years |
|
Definition
|
|
Term
| As MS progresses, what happens to Brain volume? |
|
Definition
|
|
Term
| MS Patterns: characterized by progression of disability from onsent with or without plateaus or minor improvements |
|
Definition
|
|
Term
| MS Patterns: only 10% of MS patients are diagnosed with this pattern |
|
Definition
|
|
Term
| MS Diagnosis: requires these two pieces of evidence |
|
Definition
| evidence of lesions on MRI in at least two distinct areas (space) and that the lesions occured at discrete points in time |
|
|
Term
| MS diagnosis: supporting evidence from what two tests |
|
Definition
| CSF, VEP (Visual Evoked Potential) |
|
|
Term
| Prognosis of MS for a favorable course (4) |
|
Definition
| female, onset before 35, monoregional vs polyregional lesions, complete recovery after exacerbation |
|
|
Term
| Prognosis in MS: factors associated with less favorable course (5) |
|
Definition
| male, onset after 35, cerebellar symptoms (tremor, nystagmus, dysarthria, ataxia), poor recovery following exacerbations, frequent attacks |
|
|
Term
| MS: Treatment of acute attacks involves what? for how long? |
|
Definition
| high dose intravenous corticosteriods for 3-5 days |
|
|
Term
| MS: Use of corticosteriods has what long term use side effects (5) |
|
Definition
| hypertension, diabetes, osteoporosis, cataracts, ulcers |
|
|
Term
| How may steroids improve function during an acute attack? |
|
Definition
| improve nerve conduction by reducing inflammation, thus leading to reduction in symptoms |
|
|
Term
|
Definition
| risk factors, congenital aneurysm |
|
|
Term
|
Definition
| embolic (cardiac primary), thrombotic, hemorrhagic (aneurysm rupture/HTN) |
|
|
Term
| pathophysiology of a stroke (6) |
|
Definition
| ischemia, infarction of neurons, with bleed compression of underlying neural tissue, development of prenumbra, learned nonuse |
|
|
Term
| the prenumbra is a secondary zone of damage composed of what |
|
Definition
| lacte and glutamate accumulation |
|
|
Term
| Nagi Model: Pathology leads to |
|
Definition
|
|
Term
| Nagi Model: Impairment leads to |
|
Definition
|
|
Term
| Nagi model: funcitonal limtation leads to |
|
Definition
|
|
Term
| Who model: disease leads to |
|
Definition
|
|
Term
| Who model: impairment leads to |
|
Definition
|
|
Term
| WHO model: disability leads to |
|
Definition
|
|
Term
| NCMRR Model: Pathology leads to |
|
Definition
|
|
Term
| NCMRR Model: impairment leads to |
|
Definition
|
|
Term
| NCMRR Model: functional limitaiton lead sto |
|
Definition
|
|
Term
| NCMRR Model: disability leads to |
|
Definition
|
|
Term
| WHO II model: pathology leads to |
|
Definition
| body structures/functions |
|
|
Term
| WHO II model: body structures/functions leads to |
|
Definition
|
|
Term
| WHO II model: activities leads to |
|
Definition
|
|
Term
| WHO II Terminology: impairment |
|
Definition
| loss or abnormality of body structure of a psychological or physiological function |
|
|
Term
| WHO II Terminology: activity limitations |
|
Definition
| performance decrements in funcitonal activities of the person |
|
|
Term
| WHO II Terminology: participation restriction |
|
Definition
| person's restrictions in involvment in life situations in the context they live (societal Level) |
|
|
Term
| 3 cortical descending pathways |
|
Definition
| corticospinal, corticobulbar, cortical inhibiting axons to subcortical nuclei |
|
|
Term
| 3 subcortical nuclei and associated descending pathways |
|
Definition
| red nucleus (rubrospinal tract), vestibular nucleus (vestibulospinal tract), reticular formation (reticulospinal tract) |
|
|
Term
|
Definition
| desending corticobulbar, ascending sensory |
|
|
Term
|
Definition
| descending corticospinal, descending pathways from subcortical nuclei, ascends sensory pathways |
|
|
Term
| 4 ascending sensory pathways of the spinal cord |
|
Definition
| dorsal column/medial lemniscus system, ant spinothalamic, lat spinothalamic, spinocerebellar |
|
|
Term
| motor components of peripheral nervous system |
|
Definition
| alpha motor neurons, gamma motor neurons |
|
|
Term
| sensory afferents of peripheral nervous system |
|
Definition
| muscle spindles, GTOs, joint proprioception, mechanoreceptors |
|
|
Term
| aa of Circle of willis (8) |
|
Definition
| vertebral, basilar, posterior communicating, internal carotid, middle cerebral, anterior cerebral, anterior communicating |
|
|
Term
| anterior cerebral aa supplies what |
|
Definition
| LE portion of the motor homunculus |
|
|
Term
| middle cerebral aa supplies what (8) |
|
Definition
| arm, face, and trunk of motor homunculus, broca's area, wernicke's area, visual radiations, basal ganglia, genu of internal capsule |
|
|
Term
| 5 impairments from lesions of motor pathways |
|
Definition
| weakness, spasticity, balance deficit, coordination deficits, sensory and perceptual deficits |
|
|
Term
| 3 types of balance deficits associated with impairments from lesions of motor pathways |
|
Definition
| somatosensory, visual, vestibular |
|
|
Term
| upper motor neuron palsy name |
|
Definition
|
|
Term
| signs of supranuclear palsy (7) |
|
Definition
| mm affected in groups, slight atrophy due to disuse, spasticity with increased DTRs, + Babinski, - fascicular twitches, normal NCV, - denervation in EMG |
|
|
Term
| Lower motor neuron palsy name |
|
Definition
|
|
Term
| infranuclear palsy signs and symptoms (7) |
|
Definition
| individual mm may be affected, atrophy pronounced 70-80%, decrease tone with decreased or 0 DTRs, -Babinski, +fasicular twitches, abnormal NCV, +EMG with fibrillation |
|
|
Term
| Upper motor neuron lesion examples (4) |
|
Definition
| CVA, MS, huntington's chorea, parkinson's, head injury |
|
|
Term
| lower motor neuron lesion examples (5) |
|
Definition
| bell's palsy, carpal tunnel, trauma/lesion to peripheral nn, guillian barre, herpes zoster |
|
|
Term
| CSF disturbance lead sto... |
|
Definition
|
|
Term
| examples of intracranial neoplams |
|
Definition
| gliomas, meningiomas, astrocytomas, meduloblastomas |
|
|
Term
| examples of nonviral infections |
|
Definition
| bacterial meningitis, bacterial encephalitis, brain abcess |
|
|
Term
| examples of viral infection |
|
Definition
| poliomyelitis, herpes zoster, acute encephalitis |
|
|
Term
|
Definition
| thrombotic, embolic, hemorrhagic |
|
|
Term
| disease of the spinal cord examples |
|
Definition
| trauma, myelitis, vascular lesions |
|
|
Term
| examples of demyelinating disease |
|
Definition
|
|
Term
| examples of degenerative disease |
|
Definition
| Alzheimer's disease, Huntington chorea, parkinson's disease |
|
|
